Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

PURPOSE: Outcomes for patients with diffuse large B-cell lymphoma remain heterogeneous, with existing methods failing to consistently predict treatment failure. We examined the additional prognostic value of circulating tumor DNA (ctDNA) before and during therapy for predicting patient outcomes. PAT...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Kurtz, David M., Scherer, Florian, Jin, Michael C., Soo, Joanne, Craig, Alexander F.M., Esfahani, Mohammad Shahrokh, Chabon, Jacob J., Stehr, Henning, Liu, Chih Long, Tibshirani, Robert, Maeda, Lauren S., Gupta, Neel K., Khodadoust, Michael S., Advani, Ranjana H., Levy, Ronald, Newman, Aaron M., Dührsen, Ulrich, Hüttmann, Andreas, Meignan, Michel, Casasnovas, René-Olivier, Westin, Jason R., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2018
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161832/
https://ncbi.nlm.nih.gov/pubmed/30125215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.78.5246
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi